Alnylam Pharmaceuticals | Egenkapital Og Reserver

Equity Capital And Reserves Endring Dato
Acadia Pharmaceuticals USD 464.04M 32.29M 2024-03
Agios Pharmaceuticals USD 743.92M 67.1M 2024-03
Alnylam Pharmaceuticals USD -219272000 1.37M 2024-03
Amgen USD 5.02B 1.21B 2024-03
Arrowhead Research USD 495.4M 335M 2024-03
Avrobio USD 88.84M 5.9M 2024-03
BioMarin Pharmaceutical USD 5.07B 122.27M 2024-03
Incyte USD 5.39B 204.43M 2024-03
Ionis Pharmaceuticals USD 296.52M 90.17M 2024-03
Moderna USD 12.82B 1.04B 2024-03
Neurocrine Biosciences USD 2.39B 384M 2024-03
Novartis USD 39.76B 6.91B 2024-03
PTC Therapeutics USD -893916000 75.36M 2024-03
Regeneron Pharmaceuticals USD 26.99B 1.02B 2024-03
Sarepta Therapeutics USD 961.19M 196.83M 2024-03
Takeda JPY 6.74T 328.42B 2023-12
Ultragenyx Pharmaceutical USD 140.26M 135.15M 2024-03
Vertex Pharmaceuticals USD 18.55B 2.03B 2024-03
Xencor USD 612.19M 56.61M 2024-03



Alnylam Pharmaceuticals Egenkapital Og Reserver - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Jun 2024.